Basics ImmunityBio, Inc. Common Stock IPO Date: July 27, 2015 Sector: Healthcare Industry: Biotech Market Cap: $2.32B Activated in VL: True Average Daily Range Avg Daily Range: $0.25 | 4.45% Avg Daily Range (30 D): $0.06 | 2.34% Avg Daily Range (90 D): $0.07 | 2.46% Institutional Daily Volume Avg Daily Volume: 3.6M Avg Daily Volume (30 D): 8.87M Avg Daily Volume (90 D): 7.89M Trade Size Avg Trade Size (Sh.): 219 Avg Trade Size (Sh.) (30 D): 435 Avg Trade Size (Sh.) (90 D): 408 Institutional Trades Total Inst.Trades: 1,218 Avg Inst. Trade: $1.87M Avg Inst. Trade (30 D): $3.44M Avg Inst. Trade (90 D): $2.32M Avg Inst. Trade Volume: .38M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.92M Avg Closing Trade (30 D): $2.47M Avg Closing Trade (90 D): $1.67M Avg Closing Volume: 370.74K     News Oct 22, 2025 @ 5:42 PM Looking For The Next Beyond Meat? Here Are The Top... Source: Erica Kollmann Sep 18, 2025 @ 11:05 AM Biotech Breakouts: 3 Stocks With Massive Upside Po... Source: Chris Markoch Sep 16, 2025 @ 4:29 PM Cancer Immunotherapy Surge Drives $258B Market as ... Source: Prnewswire Aug 28, 2025 @ 2:44 PM FDA Tightens Survival Standards as Cancer Drug Pip... Source: Prnewswire Jul 9, 2025 @ 12:30 PM Breaking Through: Systemic Genetic Medicines for H... Source: Prnewswire Financials   TTM Q1 2025 Q3 2024 Basic EPS $-.1 $-.15 $-.12 Diluted EPS $-.1 $-.15 $-.14 Revenue $ 26.43M $ 16.52M $ 6.11M Gross Profit $ 26.29M $ 16.46M $ Net Income / Loss $ -92.57M $ -129.67M $ -85.75M Operating Income / Loss $ -71.29M $ -64.43M $ -80.25M Cost of Revenue $ .14M $ .06M $ M Net Cash Flow $ 76.92M $ -82.76M $ -18.15M PE Ratio